CC
CELG

Capital Counsel’s Celgene Corp CELG Stock Holding History

Capital Counsel’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,649
Closed -$240K – 66
2017
Q3 		$240K Hold
1,649
– – 0.02% 55
2017
Q2 		$214K Buy
1,649
+6
+0.4% +$735 0.02% 57
2017
Q1 		$204K Buy
+1,643
New +$197K 0.02% 63
2016
Q1 		– Sell
-3,083
Closed -$369K – 131
2015
Q4 		$369K Sell
3,083
-200
-6% -$23.1K 0.02% 96
2015
Q3 		$355K Sell
3,283
-300
-8% -$37.2K 0.02% 88
2015
Q2 		$415K Buy
3,583
+164
+5% +$18.7K 0.02% 93
2015
Q1 		$394K Sell
3,419
-607
-15% -$72.5K 0.02% 95
2014
Q4 		$450K Hold
4,026
– – 0.02% 86
2014
Q3 		$382K Hold
4,026
– – 0.02% 88
2014
Q2 		$346K Sell
4,026
-1,250
-24% -$95.1K 0.02% 98
2014
Q1 		$368K Hold
5,276
– – 0.02% 96
2013
Q4 		$446K Buy
+5,276
New +$417K 0.03% 91

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital Counsel's CELG Position: Q4 2017 in Review

Capital Counsel sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 1,649 shares — an estimated $240K sold.

Capital Counsel first reported a position in CELG in Q4 2013 and held it in 12 quarters. The position peaked at $450K in Q4 2014. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Capital Counsel reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Capital Counsel sold 1,649 Celgene Corp shares in Q4 2017, an estimated $240K.
  • Capital Counsel first reported a position in Celgene Corp in Q4 2013 and held it in 12 quarters.
  • Capital Counsel's Celgene Corp position peaked at $450K in Q4 2014.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Capital Counsel's 13F filing for Q4 2017, filed 13 Feb 2018.